Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects

• DOI: 10.1007/s00125-011-2137-1
• Publication Date: 2011-04-04T14:26:09Z
• Authors: N. Klöting; P. Kovacs; M. Kern; J. T. Heiker; M. Fasshauer; M. R. Schön; M. Stumvoll; A. G. Beck-Sickinger; M. Blüher
• Keywords: Blood Glucose; 2. Zero hunger; 0301 basic medicine; Serine Proteinase Inhibitors; Blotting, Western; Enzyme-Linked Immunosorbent Assay; In Vitro Techniques; 12. Responsible consumption; 3. Good health; Mice, Inbred C57BL; Eating; Mice; 03 medical and health sciences; Animals; Humans; Female; Serpins

Vaspin (visceral adipose tissue-derived serpin) was first identified as an adipokine in a rat model of type 2 diabetes, in which it is predominantly secreted from visceral adipose tissue. Serum concentrations of vaspin show a food intake-related diurnal variation. We therefore tested the hypothesis that vaspin plays a role in the regulation of food intake.Vaspin levels in the hypothalamus and human stomach were determined by western blotting. The cerebrospinal fluid concentration of vaspin was measured in five healthy volunteers using an ELISA. Fed 11-week-old female db/db mice were given intraperitoneal injections of 1 mg/kg body weight of vaspin (n = 6) or saline (n = 6) on experimental days 1, 3 and 4. Changes in food intake and fed plasma glucose concentrations were determined after one intracerebroventricular administration of either 1 μg vaspin or artificial cerebrospinal fluid into 11-week-old female db/db (n = 8) and C57BL/6 mice (n = 8) up to 6 days after injection.We detected vaspin in the hypothalamus of db/db and C57BL/6 mice and in the cerebrospinal fluid of healthy individuals. Both peripheral and central vaspin administration decrease food intake in obese db/db and lean C57BL/6 mice. In db/db mice, vaspin treatment is associated with sustained glucose-lowering effects for at least 6 days after injection. In addition, we demonstrated expression of the gene encoding vaspin in the gastric mucosa in humans, and found that this was subject to regional variations.Our data suggest a previously unrecognised role of vaspin in the regulation of food intake. We postulate that vaspin inhibits a protease that degrades an anti-orexigenic factor.